Publication: 2170

A phase II trial of the Src-kinase inhibitor saracatinib after 4 cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621
      QxMD      Google Scholar   
Citation:
Lung Cancer vol 85 (2) 245-250
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
3
Parents:
623  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA180821, U10 CA180882  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
NCCTG-N0621
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Small cell lung cancer, saracatinib, C-Src